These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25259627)

  • 1. Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides.
    Snášel J; Nauš P; Dostál J; Hnízda A; Fanfrlík J; Brynda J; Bourderioux A; Dušek M; Dvořáková H; Stolaříková J; Zábranská H; Pohl R; Konečný P; Džubák P; Votruba I; Hajdúch M; Rezáčová P; Veverka V; Hocek M; Pichová I
    J Med Chem; 2014 Oct; 57(20):8268-79. PubMed ID: 25259627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Substituted 6-(Het)aryl-7-deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity.
    Malnuit V; Slavětínská LP; Nauš P; Džubák P; Hajdúch M; Stolaříková J; Snášel J; Pichová I; Hocek M
    ChemMedChem; 2015 Jun; 10(6):1079-93. PubMed ID: 25882678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution crystal structures of Mycobacterium tuberculosis adenosine kinase: insights into the mechanism and specificity of this novel prokaryotic enzyme.
    Reddy MCM; Palaninathan SK; Shetty ND; Owen JL; Watson MD; Sacchettini JC
    J Biol Chem; 2007 Sep; 282(37):27334-27342. PubMed ID: 17597075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis. I. Modifications to the adenine moiety.
    Long MC; Parker WB
    Biochem Pharmacol; 2006 Jun; 71(12):1671-82. PubMed ID: 16620788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CycloSal-phosphate pronucleotides of cytostatic 6-(Het)aryl-7-deazapurine ribonucleosides: Synthesis, cytostatic activity, and inhibition of adenosine kinases.
    Spácilová P; Naus P; Pohl R; Votruba I; Snásel J; Zábranská H; Pichová I; Ameral R; Birkus G; Cihlár T; Hocek M
    ChemMedChem; 2010 Aug; 5(8):1386-96. PubMed ID: 20533504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.
    Toti KS; Osborne D; Ciancetta A; Boison D; Jacobson KA
    J Med Chem; 2016 Jul; 59(14):6860-77. PubMed ID: 27410258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cytostatic, antimicrobial, and anti-HCV activity of 6-substituted 7-(het)aryl-7-deazapurine ribonucleosides.
    Nauš P; Caletková O; Konečný P; Džubák P; Bogdanová K; Kolář M; Vrbková J; Slavětínská L; Tloušt'ová E; Perlíková P; Hajdúch M; Hocek M
    J Med Chem; 2014 Feb; 57(3):1097-110. PubMed ID: 24397620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytostatic and antiviral activities of 2'-deoxy-2',2'-difluororibo- and 2'-deoxy-2'-fluororibonucleosides derived from 7-(Het)aryl-7-deazaadenines.
    Perlíková P; Eberlin L; Ménová P; Raindlová V; Slavětínská L; Tloušťová E; Bahador G; Lee YJ; Hocek M
    ChemMedChem; 2013 May; 8(5):832-46. PubMed ID: 23559483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing the structural coverage of tuberculosis drug targets.
    Baugh L; Phan I; Begley DW; Clifton MC; Armour B; Dranow DM; Taylor BM; Muruthi MM; Abendroth J; Fairman JW; Fox D; Dieterich SH; Staker BL; Gardberg AS; Choi R; Hewitt SN; Napuli AJ; Myers J; Barrett LK; Zhang Y; Ferrell M; Mundt E; Thompkins K; Tran N; Lyons-Abbott S; Abramov A; Sekar A; Serbzhinskiy D; Lorimer D; Buchko GW; Stacy R; Stewart LJ; Edwards TE; Van Voorhis WC; Myler PJ
    Tuberculosis (Edinb); 2015 Mar; 95(2):142-8. PubMed ID: 25613812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing the chemical scaffold of the anti-arthritic drug Lobenzarit to target tryptophan biosynthesis in Mycobacterium tuberculosis.
    Evans GL; Gamage SA; Bulloch EM; Baker EN; Denny WA; Lott JS
    Chembiochem; 2014 Apr; 15(6):852-64. PubMed ID: 24623674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
    Braendvang M; Bakken V; Gundersen LL
    Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosis.
    Krajczyk A; Zeidler J; Januszczyk P; Dawadi S; Boshoff HI; Barry CE; Ostrowski T; Aldrich CC
    Bioorg Med Chem; 2016 Jul; 24(14):3133-43. PubMed ID: 27265685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase.
    Crespo RA; Dang Q; Zhou NE; Guthrie LM; Snavely TC; Dong W; Loesch KA; Suzuki T; You L; Wang W; O'Malley T; Parish T; Olsen DB; Sacchettini JC
    J Med Chem; 2019 May; 62(9):4483-4499. PubMed ID: 31002508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halting ionic shuttle to disrupt the synthetic machinery-Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis.
    Salifu EY; Agoni C; Olotu FA; Dokurugu YM; Soliman MES
    J Cell Biochem; 2019 Sep; 120(9):16108-16119. PubMed ID: 31125144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine Kinase couples sensing of cellular potassium depletion to purine metabolism.
    de Oliveira RR; Morales-Neto R; Rocco SA; Sforça ML; Polo CC; Tonoli CCC; Mercaldi GF; Cordeiro AT; Murakami MT; Franchini KG
    Sci Rep; 2018 Aug; 8(1):11988. PubMed ID: 30097648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors.
    Nilsson MT; Krajewski WW; Yellagunda S; Prabhumurthy S; Chamarahally GN; Siddamadappa C; Srinivasa BR; Yahiaoui S; Larhed M; Karlén A; Jones TA; Mowbray SL
    J Mol Biol; 2009 Oct; 393(2):504-13. PubMed ID: 19695264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative protein modeling of methionine S-adenosyltransferase (MAT) enzyme from Mycobacterium tuberculosis: a potential target for antituberculosis drug discovery.
    Khedkar SA; Malde AK; Coutinho EC
    J Mol Graph Model; 2005 Jan; 23(4):355-66. PubMed ID: 15670956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Gising J; Nilsson MT; Odell LR; Yahiaoui S; Lindh M; Iyer H; Sinha AM; Srinivasa BR; Larhed M; Mowbray SL; Karlén A
    J Med Chem; 2012 Mar; 55(6):2894-8. PubMed ID: 22369127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.
    Renuka J; Reddy KI; Srihari K; Jeankumar VU; Shravan M; Sridevi JP; Yogeeswari P; Babu KS; Sriram D
    Bioorg Med Chem; 2014 Sep; 22(17):4924-34. PubMed ID: 25129171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cordycepin kills Mycobacterium tuberculosis through hijacking the bacterial adenosine kinase.
    Huang F; Li W; Xu H; Qin H; He ZG
    PLoS One; 2019; 14(6):e0218449. PubMed ID: 31199855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.